Palonosetron hydrochloride for chemotherapy-induced nausea and vomiting in hepatocellular carcinoma treated with TACE
LU Ai-xia
Abstract
LU Ai-xia
Abstract
Objective To observe the efficacy of Palonosetron hydrochloride injection for preventing chemotherapy-induced nausea and vomiting in hepatocellular carcinoma treated with TACE(transcatheter arterial chemoembolization).Methods 48 patients with hepatocellular carcinoma who underwent TACE were randomly divided into two groups: observation group and control group.Palonosetron hydrochloride was given to the observation group intravenously in a dose of 0.25 mg 30 min before TACE while Granisetron hydrochloride to the control group in a dose of 6 mg.The symptoms of nausea and vomiting and adverse reaction were compared in both groups on day 1,3 after TACE.Results The total effective rate for nausea was 95.83% and 87.50% in the observation group and control group respectively on day 1 after TACE,while the total effective rate for vomiting was 100.00% and 87.50% respectively.Significant difference was found in the two groups(both P0.05).The total effectiveness rate for nausea was 91.67% and 54.16% in the observation group and control group respectively on day 3 after TACE,while the total effectiveness rate for vomiting was 83.33% and 50.00% respectively.There was significant difference between the two groups(both P0.05).The incidence of adverse reaction was 4.16% in both groups,which showed no significant difference(P0.05).Conclusions Palonosetron hydrochloride is an efficient antiemetic for hepatocellular carcinoma treated with TACE.The long lasting action makes it more effective for late onset vomiting.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the efficacy of Palonosetron hydrochloride injection for preventing chemotherapy-induced nausea and vomiting in hepatocellular carcinoma treated with TACE(transcatheter arterial chemoembolization).Methods 48 patients with hepatocellular carcinoma who underwent TACE were randomly divided into two groups: observation group and control group.Palonosetron hydrochloride was given to the observation group intravenously in a dose of 0.25 mg 30 min before TACE while Granisetron hydrochloride to the control group in a dose of 6 mg.The symptoms of nausea and vomiting and adverse reaction were compared in both groups on day 1,3 after TACE.Results The total effective rate for nausea was 95.83% and 87.50% in the observation group and control group respectively on day 1 after TACE,while the total effective rate for vomiting was 100.00% and 87.50% respectively.Significant difference was found in the two groups(both P0.05).The total effectiveness rate for nausea was 91.67% and 54.16% in the observation group and control group respectively on day 3 after TACE,while the total effectiveness rate for vomiting was 83.33% and 50.00% respectively.There was significant difference between the two groups(both P0.05).The incidence of adverse reaction was 4.16% in both groups,which showed no significant difference(P0.05).Conclusions Palonosetron hydrochloride is an efficient antiemetic for hepatocellular carcinoma treated with TACE.The long lasting action makes it more effective for late onset vomiting.
Key concepts: Nausea, Vomiting, Medicine, Hepatocellular carcinoma, Palonosetron, Anesthesia, Adverse effect, Antiemetic